PDCD4 Antikörper (AA 1-260)
-
- Target Alle PDCD4 Antikörper anzeigen
- PDCD4 (Programmed Cell Death 4 (PDCD4))
-
Bindungsspezifität
- AA 1-260
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PDCD4 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunoprecipitation (IP)
- Kreuzreaktivität
- Human
- Aufreinigung
- Antigen Affinity Purified
- Immunogen
- Recombinant Human Programmed cell death protein 4 protein (1-260AA)
- Isotyp
- IgG
- Top Product
- Discover our top product PDCD4 Primärantikörper
-
-
- Applikationshinweise
- Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200, IP:1:200-1:2000,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- PDCD4 (Programmed Cell Death 4 (PDCD4))
- Andere Bezeichnung
- PDCD4 (PDCD4 Produkte)
- Synonyme
- H731 antikoerper, D19Ucla1 antikoerper, Ma3 antikoerper, Tis antikoerper, Dug antikoerper, cb45 antikoerper, pdcd4 antikoerper, sb:cb45 antikoerper, wu:fc84b08 antikoerper, h731 antikoerper, MGC69337 antikoerper, PDCD4 antikoerper, wu:fa55g03 antikoerper, wu:fb08a11 antikoerper, wu:fe01a02 antikoerper, zgc:66311 antikoerper, programmed cell death 4 antikoerper, programmed cell death 4b antikoerper, programmed cell death 4 L homeolog antikoerper, programmed cell death 4 (neoplastic transformation inhibitor) antikoerper, programmed cell death 4a antikoerper, PDCD4 antikoerper, Pdcd4 antikoerper, pdcd4b antikoerper, pdcd4.L antikoerper, pdcd4 antikoerper, pdcd4a antikoerper
- Hintergrund
-
Background: Inhibits translation initiation and cap-dependent translation. May excert its function by hindering the interaction between EIF4A1 and EIF4G. Inhibits the helicase activity of EIF4A. Modulates the activation of JUN kinase. Down-regulates the expression of MAP4K1, thus inhibiting events important in driving invasion, namely, MAPK85 activation and consequent JUN-dependent transcription. May play a role in apoptosis. Tumor suppressor. Inhibits tumor promoter-induced neoplastic transformation. Binds RNA .
Aliases: Death up-regulated gene protein antibody, Dug antibody, H731 antibody, Ma3 antibody, MGC33046 antibody, MGC33047 antibody, Neoplastic transformation inhibitor antibody, Neoplastic transformation inhibitor protein antibody, Nuclear antigen H731 antibody, Nuclear antigen H731 like antibody, Nuclear antigen H731 like protein antibody, Nuclear antigen H731-like antibody, PDCD 4 antibody, Pdcd4 antibody, PDCD4_HUMAN antibody, Programmed cell death 4 antibody, programmed cell death 4 (neoplastic transformation inhibitor) antibody, Programmed cell death protein 4 antibody, Protein 197/15a antibody, Protein MA-3 antibody, Tis antibody, Topoisomerase-inhibitor suppressed protein antibody
- UniProt
- Q53EL6
-